Table 2. Comparison of clinical characteristics in ankylosing spondylitis and healthy controls.
Variables | Ankylosing spondylitis | Healthy controls | p Value |
---|---|---|---|
n | 30 | 25 | |
EPC % | 0.020 ± 0.001 | 0.040 ± 0.010 | < 0.001 |
FMD % | 7.35 ± 2.54 | 10.27 ± 1.73 | 0.002 |
CIMT (cm) | 0.63 ± 0.01 | 0.35 ± 0.02 | < 0.001 |
TNF-α (pg/mL) | 5.07 ± 2.04 | 3.6 ± 1.5 | 0.001 |
IL-6 (pg/mL) | 8.77 ± 3.67 | 4.2 ± 2.83 | 0.004 |
IL-1 (pg/mL) | 179.0 ± 74.8 | 102.4 ± 36.3 | 0.001 |
Abbreviations: CIMT, carotid intima-media thickness; EPC, endothelial progenitor cells; FMD, flow-mediated dilatation; IL-1, interleukin-1; IL-6, interleukin-6; TNF-α, tumor necrosis factor-α.
Note: Values are mean ± SD. Values in bold indicate, p-value < 0.05.